An oral-liquid, pediatric form of crizotinib designed for use by pediatric patients is being tested for its' palatability in adults.
Taste assessment of new formulation. Subjects will not ingest the drug.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
5
Oral liquid. Taste assessment of new formulation. Subjects will not ingest the drug.
Pfizer Investigational Site
Woburn, Massachusetts, United States
A complete description of the sensory attributes of drug product prototype formulations (eg, aroma, flavor, texture, and mouthfeel).
Time frame: 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.